Skip to main content

Table 2 Change in management based on biopsy

From: Biopsy confirmation of metastatic sites in breast cancer patients: clinical impact and future perspectives

Reference Number of patients Therapy changed (%)
Lindstrom et al. [7] 1,010 23 (HER2) 50 (ER)
Curigliano et al. [9] 255 12.1
Amir et al. [2] 289 14.2
Bogina et al. [11] 140 7.3
Amir et al. [4] 121 14
Simmons et al. [15] 40 20
Thompson et al. [5] 137 17.5
  1. ER, estrogen receptor; HER2, human epidermal growth factor receptor 2.